-
Mashup Score: 5
The 2020 European Society of Cardiology (ESC) guidelines for the diagnosis and management of patients with non-ST elevation-acute coronary syndrome (NSTE-ACS) recommend early invasive coronary angiography in high-risk patients and no routine pre-treatment with oral P2Y12 receptor inhibitor in NSTE-ACS patients prior to defining coronary anatomy.
Categories: General Medicine News, CardiologistsTweet
-
Mashup Score: 13Left ventricular global work index and prediction of cardiovascular mortality after transcatheter aortic valve implantation - 4 month(s) ago
Echocardiography is used for assessment of patients after transcatheter aortic valve implantation (TAVI). Global work index (GWI) integrates LV deformation throughout the cardiac cycle and LV afterload and may be advantageous for long-term follow-up.
Categories: General Medicine News, CardiologistsTweet
-
Mashup Score: 13Left ventricular global work index and prediction of cardiovascular mortality after transcatheter aortic valve implantation - 4 month(s) ago
Echocardiography is used for assessment of patients after transcatheter aortic valve implantation (TAVI). Global work index (GWI) integrates LV deformation throughout the cardiac cycle and LV afterload and may be advantageous for long-term follow-up.
Categories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
The 2020 European Society of Cardiology (ESC) guidelines for the diagnosis and management of patients with non-ST elevation-acute coronary syndrome (NSTE-ACS) recommend early invasive coronary angiography in high-risk patients and no routine pre-treatment with oral P2Y12 receptor inhibitor in NSTE-ACS patients prior to defining coronary anatomy.
Categories: General Medicine News, CardiologistsTweet-
@gbiondizoccai @JACCJournals In the READAPT survey of 17 European countries, we found that time to invasive procedure for NSTEACS was short, with the exception of the UK where it was not uncommon to have durations >24 hrs before invasive strategy & where pretreatment is commonplace. https://t.co/mGizxyz5Ip
-
-
Mashup Score: 7
The athlete’s heart is a well-known phenomenon characterized by a harmonic remodelling that affects the cardiac chambers. However, whether mild-to-moderate aortic dilatation can be considered normal in athletes is debated. This study aimed to evaluate the ratio between left ventricular (LV) size and aortic dimensions, reporting the normal values of the ratio between the aortic root diameters at the level of the sinuses of Valsalva and LV diameters (AoD/LVEDD ratio) in a wide cohort of competitive athletes.
Categories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 6
Premature ventricular beats (PVBs) are recorded in a sizeable proportion of athletes during pre-participation screening, especially if the evaluation includes both resting and exercise ECG. While in the majority of cases no underlying heart disease is present, in others PVBs may be the sign of a condition at risk of sudden cardiac death, including cardiomyopathies, congenital, coronary artery, heart valves and ion channels diseases. In this expert opinion document of the Italian Society of Sports Cardiology, we propose a multiparametric interpretation approach to PVBs in athletes and a stepwise diagnostic algorithm.
Categories: General Medicine News, CardiologistsTweet
-
Mashup Score: 7Proposed diagnostic criteria for arrhythmogenic cardiomyopathy. European Task Force consensus report1 - 6 month(s) ago
Arrhythmogenic cardiomyopathy (ACM) is a heart muscle disease characterized by prominent ānon-ischemicā myocardial scarring predisposing to ventricular electrical instability. Diagnostic criteria for the original phenotype, arrhythmogenic right ventricular cardiomyopathy (ARVC), were first proposed in 1994 and revised in 2010 by an international Task Force (TF). A 2019 International Expert report appraised these previous criteria, finding good accuracy for diagnosis of ARVC but a lack of sensitivity for identification of the expanding phenotypic disease spectrum, which includes left-sided variants, i.e., biventricular (ABVC) and arrhythmogenic left ventricular cardiomyopathy (ALVC).
Categories: General Medicine News, CardiologistsTweet
-
Mashup Score: 5Proposed diagnostic criteria for arrhythmogenic cardiomyopathy. European Task Force consensus report1 - 6 month(s) ago
Arrhythmogenic cardiomyopathy (ACM) is a heart muscle disease characterized by prominent ānon-ischemicā myocardial scarring predisposing to ventricular electrical instability. Diagnostic criteria for the original phenotype, arrhythmogenic right ventricular cardiomyopathy (ARVC), were first proposed in 1994 and revised in 2010 by an international Task Force (TF). A 2019 International Expert report appraised these previous criteria, finding good accuracy for diagnosis of ARVC but a lack of sensitivity for identification of the expanding phenotypic disease spectrum, which includes left-sided variants, i.e., biventricular (ABVC) and arrhythmogenic left ventricular cardiomyopathy (ALVC).
Categories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 3Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial - 7 month(s) ago
Canagliflozin is a sodiumāglucose cotransporter 2 inhibitor that has been shown to reduce cardiovascular events in diabetic patients with and without heart failure (HF). Whether the clinical benefits and safety profile of canagliflozin are different in those on a beta blocker and an angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (BBĀ +Ā RAASi) is unknown.
Categories: General Medicine News, CardiologistsTweet
We identified geographic variation in the use of oral P2Y12 inhibitor pre-treatment, suggesting heterogeneous implementation of the guidelines. Results from the REal-world ADoption survey focus on Acute antiPlatelet Treatment (READAPT) survey @IJCardio https://t.co/eH5yyFvNxB